ArticleFrontiers in pharmacology2020

Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Shikonin in Colon Cancer.

Yang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.